InventisBio Co., Limited

Shanghai clinical-stage biotech developing drugs for cancer, autoimmune and metabolic diseases

What InventisBio does

InventisBio is a Shanghai drug developer working on new medicines for cancer, immune system disorders and metabolic diseases such as gout. Several of its drug candidates are in late-stage human trials, including treatments for lung, colorectal and breast cancer. It also has earlier-stage research programs aimed at solid tumors and allergic conditions like eczema and asthma.

How InventisBio makes money

As a clinical-stage biotech, it invests in research and clinical trials, aiming to earn revenue by bringing its drug candidates to market in China or through partnerships and licensing.

Products & services

• Befoternitib (BPI-D0316)
• Garsorasib (D-1553)
• Taragarestrant (D-0502)
• D2570
• Darbinurad (D-0120)